Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Tourmaline Bio, Inc. is a biotechnology company developing innovative medicines targeting immune and inflammatory diseases. Its lead candidate, pacibekitug, is a fully human monoclonal antibody that inhibits IL-6, a cytokine involved in autoimmune and inflammatory conditions. The company focuses on high unmet medical needs, advancing therapies for cardiovascular inflammation, thyroid eye disease, and other autoimmune disorders through clinical trials and strategic collaborations.
This description was generated via AI from an annual report. Updated about 1 year ago.